Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

NSE:SUNPHARMA Statistics

Total Valuation

NSE:SUNPHARMA has a market cap or net worth of INR 4.07 trillion. The enterprise value is 3.84 trillion.

Market Cap	4.07T
Enterprise Value	3.84T

Important Dates

The last earnings date was Saturday, January 31, 2026.

Earnings Date	Jan 31, 2026
Ex-Dividend Date	Feb 5, 2026

Share Statistics

NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has increased by 0.24% in one year.

Current Share Class	2.40B
Shares Outstanding	2.40B
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	12.01%
Owned by Institutions (%)	29.65%
Float	1.06B

Valuation Ratios

The trailing PE ratio is 37.29 and the forward PE ratio is 33.30. NSE:SUNPHARMA's PEG ratio is 2.83.

PE Ratio	37.29
Forward PE	33.30
PS Ratio	7.16
PB Ratio	5.21
P/TBV Ratio	7.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.83

Enterprise Valuation

EV / Earnings	35.21
EV / Sales	6.77
EV / EBITDA	23.84
EV / EBIT	28.24
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.07
Debt / EBITDA	0.32
Debt / FCF	n/a
Interest Coverage	45.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	18.26%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.76%
Revenue Per Employee	13.21M
Profits Per Employee	2.54M
Employee Count	43,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:SUNPHARMA has paid 38.20 billion in taxes.

Income Tax	38.20B
Effective Tax Rate	25.86%

Stock Price Statistics

The stock price has decreased by -2.58% in the last 52 weeks. The beta is 0.09, so NSE:SUNPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-2.58%
50-Day Moving Average	1,724.47
200-Day Moving Average	1,691.51
Relative Strength Index (RSI)	55.32
Average Volume (20 Days)	3,364,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:SUNPHARMA had revenue of INR 568.09 billion and earned 109.15 billion in profits. Earnings per share was 45.45.

Revenue	568.09B
Gross Profit	446.18B
Operating Income	136.57B
Pretax Income	147.73B
Net Income	109.15B
EBITDA	160.25B
EBIT	136.57B
Earnings Per Share (EPS)	45.45

Balance Sheet

The company has 278.80 billion in cash and 52.15 billion in debt, with a net cash position of 226.65 billion or 94.47 per share.

Cash & Cash Equivalents	278.80B
Total Debt	52.15B
Net Cash	226.65B
Net Cash Per Share	94.47
Equity (Book Value)	781.27B
Book Value Per Share	324.46
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 78.54%, with operating and profit margins of 24.04% and 19.21%.

Gross Margin	78.54%
Operating Margin	24.04%
Pretax Margin	26.01%
Profit Margin	19.21%
EBITDA Margin	28.21%
EBIT Margin	24.04%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.94%.

Dividend Per Share	16.00
Dividend Yield	0.94%
Dividend Growth (YoY)	6.45%
Years of Dividend Growth	7
Payout Ratio	36.30%
Buyback Yield	-0.24%
Shareholder Yield	0.71%
Earnings Yield	2.68%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jul 29, 2013
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	2